A pathophysiologic framework for the overlap of disorders of gut-brain interaction and the role of the gut microbiome
Ayesha Shah Yeong Yeh Lee Hidekazu Suzuki Joash Tan-Loh Kewin Tien Ho Siah Kok-Ann Gwee Thomas Fairlie Nicholas J. Talley Uday C Ghoshal Yen-Po Wang Yong Sung Kim Gerald Holtmann a Faculty of Medicine,The University of Queensland,Brisbane,Australiab Department of Gastroenterology and Hepatology,Translational Research Institute,Princess Alexandra Hospital,Brisbane,Australiac School of Medical Sciences,Universiti Sains Malaysia,Kota Bharu,Malaysiad Division of Gastroenterology and Hepatology,Department of Internal Medicine,Tokai University School of Medicine,Isehara,Japane Division of Gastroenterology Hepatology,Department of Internal Medicine,Hospital Kuala Lumpur,Kuala Lumpur,Malaysiaf Division of Gastroenterology and Hepatology,University Medicine Cluster,National University Hospital,Singaporeg Department of Medicine,Yong Loo Lin School of Medicine,National University of Singapore,Singapore City,Singaporeh School of Medicine and Public Health,and Hunter Medical Research Institute,the University of Newcastle,Newcastle,Australiai Institute of Gastrosciences & Liver Transplantation,Apollo Multispeciality Hospitals,Kolkata,Indiaj Endoscopy centre for Diagnosis of Treatment,Department of Medicine,Taipei Veterans General Hospital,Taipei,Taiwank Digestive Disease Research Institute,Wonkwang University College of Medicine,Iksan,Koreal Good Breath Clinic,Gunpo,Korea
DOI: https://doi.org/10.1080/19490976.2024.2413367
IF: 12.2
2024-11-02
Gut Microbes
Abstract:The International Rome Committee defines Disorders of Gut-Brain Interactions (DGBI) based upon distinct combinations of chronic and/or recurrent unexplained gastrointestinal symptoms. Yet patients often experience overlapping DGBI. Patients with DGBI frequently also suffer from extraintestinal symptoms, including fatigue, sleep disturbances, anxiety, and depression. Patients with overlapping DGBI typically experience more severe GI symptoms and increased psychosocial burden. Concerning the pathophysiology, DGBI are associated with disruptions in gut motility, function of the brain and enteric neurons, immune function, and genetic markers, with recent findings revealing gut microbiome alterations linked to these mechanisms of DGBI. Emerging evidence summarized in this review suggests that the microbiome influences various established disease mechanisms of different DGBI groups. Overall, changes in the gastrointestinal microbiome do not seem to be linked to a specific DGBI subgroup but may play a key role in the manifestation of different DGBI and, subsequently, overlap of DGBI. Understanding these shared mechanisms and the role of the gastrointestinal microbiome, particularly for overlapping DGBI, might aid in developing more precise diagnostic criteria and treatment strategies while developing personalized interventions that target specific mechanisms to improve patient outcomes.
gastroenterology & hepatology,microbiology